Skip to main content
Caplight Logo









Resolute Science

Resolute Science

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://resolutescience.com/

Last Round

Seed Round

Apr 3, 2026

Total Funding Raised

$4.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Resolute Science is a biotechnology company that is advancing a pipeline of first-in-class synthetic drug conjugates for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug delivery platformtargeted cancer therapysolid tumorstumor-associated macrophagesTAMsdrug discoveryoncology biotechpreclinical researchsarcoma treatmentdrug conjugatesbiotech startuptherapeutic pipelinecancer drug developmentbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resolute Science Comparables

Compare Resolute Science with similar companies based on industry and business-model similarity.

Resolute Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Macrophage Therapeutics, Inc.
82%
United Immunity, Co., Ltd.
82%
Thunder Biotech
79%

Resolute Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 3, 2026
SeedFeb 5, 2025
GrantSep 24, 2024
AcceleratorSep 11, 2024
GrantJul 11, 2024
Grant
Aug 1, 2023

Resolute Science Investors

Notable investors and investment history

Resolute Science investors
InvestorRounds
National Cancer InstituteGrant
CureboundGrant
TL FoundationAccelerator
NuFundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    $3M Seed Round raised

  • May 5, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Resolute Science Filings

Explore SEC and related filing metadata, where available.

Resolute Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Resolute Science's valuation, stock price, and market status.

Is Resolute Science a public or private company?

Resolute Science is a private company.

What is the current stock price of Resolute Science?

Resolute Science is a private company with no public stock price. No recent secondary market data is available.

How much is Resolute Science worth (valuation)?

Valuation information for Resolute Science is not publicly available.

Can I buy Resolute Science stock?

Resolute Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Resolute Science's last funding round?

Resolute Science's most recent funding round was Seed Round on April 3, 2026.

Who are the main investors in Resolute Science?

Key investors in Resolute Science include NuFund.

Will Resolute Science IPO soon?

No public IPO plans have been announced for Resolute Science.

How can I track Resolute Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resolute Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range6
Year Founded2020
Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?